Literature DB >> 15719217

Influence of inflammatory nociception on the anxiolytic-like effect of diazepam and buspirone in rats.

A Fernández-Guasti1, R Reyes, L Martínez-Mota, F J López-Muñoz.   

Abstract

RATIONALE: The effect of anxiety on nociception has been evaluated but not that of nociception on anxiety.
OBJECTIVE: The study was conducted to analyse the influence of nociception on basal levels of anxiety-like behaviour and on the action of anxiolytic drugs.
METHODS: Nociception was induced by an intra-articular injection of uric acid at 3.75 or 7.5%. Experimental anxiety was determined in the rat burying behaviour and the elevated plus maze tests. To separate specific anxiety-related drug actions, a spontaneous ambulatory test was included. The anxiolytics, buspirone (2.5 and 5.0 mg/kg, i.p.) and diazepam (0.5, 1.0 and 2.0 mg/kg, i.p.), were used.
RESULTS: In the nociception test, the pain-induced functional impairment rat model, uric acid at 3.75 and 7.5% had an effect of around 35 and 75%, respectively. Uric acid (UA) at the lower dose (3.75%) lacked an effect on burying behaviour but significantly increased the time spent and number of entries to the open arms; the higher UA dose (7.5%) produced a significant increase in the time spent and number of entries to the open arms and a statistically significant reduction in cumulative burying. Diazepam and buspirone produced a clear dose-dependent reduction in cumulative burying. In the plus maze, diazepam also induced an increase in the time spent and number of entries to the open arms. In the burying behaviour test, rats with a mild level of nociception (uric acid at 7.5%) were insensitive to the anxiolytic-like effect of these anxiolytic drugs. In the plus maze test, the anxiolytic-like effect of diazepam (1.0 mg/kg) was blocked under both levels of nociception.
CONCLUSIONS: These data demonstrate that nociception modifies the response to anxiolytic drugs. The role of factors with anxiogenic properties produced during inflammation, which may modify diazepam and buspirone effects, is discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15719217     DOI: 10.1007/s00213-005-2190-x

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  38 in total

1.  Changes in burying behavior during the estrous cycle: effect of estrogen and progesterone.

Authors:  A Fernandez-Guasti; O Picazo
Journal:  Psychoneuroendocrinology       Date:  1992-11       Impact factor: 4.905

2.  Reduction of acute inflammation in rats by diazepam: role of peripheral benzodiazepine receptors and corticosterone.

Authors:  R Lazzarini; B E Malucelli; J Palermo-Neto
Journal:  Immunopharmacol Immunotoxicol       Date:  2001-05       Impact factor: 2.730

3.  Animal models for the study of anti-anxiety agents: a review.

Authors:  D Treit
Journal:  Neurosci Biobehav Rev       Date:  1985       Impact factor: 8.989

4.  The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine.

Authors:  L Singh; M J Field; P Ferris; J C Hunter; R J Oles; R G Williams; G N Woodruff
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

Review 5.  Gender, anxiety, and experimental pain sensitivity: an overview.

Authors:  Allan Jones; Robert Zachariae
Journal:  J Am Med Womens Assoc (1972)       Date:  2002

6.  Diazepam, but not buspirone, induces similar anxiolytic-like actions in lactating and ovariectomized Wistar rats.

Authors:  A Fernández-Guasti; A Ferreira; O Picazo
Journal:  Pharmacol Biochem Behav       Date:  2001-09       Impact factor: 3.533

7.  Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients.

Authors:  R Edwards; M Peet; J Shay; D Horrobin
Journal:  J Affect Disord       Date:  1998-03       Impact factor: 4.839

8.  Neurobehavioral alterations in mice with a targeted deletion of the tumor necrosis factor-alpha gene: implications for emotional behavior.

Authors:  K Yamada; R Iida; Y Miyamoto; K Saito; K Sekikawa; M Seishima; T Nabeshima
Journal:  J Neuroimmunol       Date:  2000-11-01       Impact factor: 3.478

9.  Morphine and dipyrone co-administration delays tolerance development and potentiates antinociception.

Authors:  Gloria P Hernández-Delgadillo; Francisco J López-Muñoz; Luis A Salazar; Silvia L Cruz
Journal:  Eur J Pharmacol       Date:  2003-05-23       Impact factor: 4.432

10.  Enhancement of antinociception by co-administration of an opioid drug (morphine) and a preferential cyclooxygenase-2 inhibitor (rofecoxib) in rats.

Authors:  Myrna Déciga-Campos; Uriah Guevara López; Maria Irene Díaz Reval; Francisco J López-Muñoz
Journal:  Eur J Pharmacol       Date:  2003-01-24       Impact factor: 4.432

View more
  1 in total

1.  Increased anxiety-like behaviors in rats experiencing chronic inflammatory pain.

Authors:  Alexandre J Parent; Nicolas Beaudet; Hélène Beaudry; Jenny Bergeron; Patrick Bérubé; Guy Drolet; Philippe Sarret; Louis Gendron
Journal:  Behav Brain Res       Date:  2012-01-08       Impact factor: 3.332

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.